SynthesisMolecular psychiatry2025
A working model linking the psychopathology and pathophysiology of major depressive disorder - an umbrella review of neuroimaging studies and a conceptual framework.
Synthesis in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Polarisation of brain dynamics in mania and depression.Dialogues in clinical neuroscience · 2026Article
- Molecular and Transcriptional Signatures of Gray Matter Volume Alterations Associated With Depressive Symptoms in Mild Cognitive Impairment.Human brain mapping · 2026Article
- Heart-Brain Axis Dysregulation in Depression: Mechanisms and Implications for Neuromodulation.Neuropsychiatric disease and treatment · 2026Review
- Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMajor depressive disorder (MDD) is a severe affective disorder with largely unknown neurobiology-partly due to the heterogeneity and often contradictory nature of existing findings.
methodsTo address this challenge, we conducted a systematic umbrella review of neuroimaging meta-analyses to identify the most consistent brain alterations associated with prototypical MDD. Data on intrinsic activity, task-based activation, and grey/white matter structure were organized by mapping alterations onto large-scale brain networks and categorizing them by early and chronic illness stages.
resultsA core pattern of brain alterations emerged. Functionally, MDD shows decreased intrinsic activity in the somatomotor-visual networks (SMN-VN) and increased activity in the ventral attention/salience network (VAN), both stable across stages; and altered activity in the default-mode network (DMN), with early decreases and chronic increases. Structurally, MDD shows decreased grey matter in the VAN across stages; early increases in SMN-VN and DMN grey matter, and widespread reductions in the chronic stage; and white matter disruption, localized early and widespread chronically. DISCUSSION: Based on these findings, we propose a conceptual framework linking psychopathology and pathophysiology of MDD. In this model, immune dysregulation and chronic inflammation act as central drivers, warping functional brain architecture-activating the insula/VAN and inhibiting SMN-VN and DMN-and triggering early structural homeostatic remodeling followed by chronic widespread deficits. This persistent network imbalance, marked by sensorimotor/SMN-VN deficits and insula/VAN hyperfunctioning, may lead to perception and psychomotor deficits along with polarization toward disembodied interoceptive imagery and related affective states, detuning brain activity and phenomenal-behavioral patterns from the environment as the core of depression.
Indexed as
Identifiers
40877467What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.